A phase II trial to investigate dodecafluoropentane emulsion (DDFPe) in patients with stroke

Trial Profile

A phase II trial to investigate dodecafluoropentane emulsion (DDFPe) in patients with stroke

Planning
Phase of Trial: Phase II

Latest Information Update: 02 Feb 2018

At a glance

  • Drugs Perflenapent (Primary)
  • Indications Stroke
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Feb 2018 New trial record
    • 31 Jan 2018 According to a NuvOx Pharmaceuticals media release, the FDA has allowed the company to proceed with this trial. The trial will be run in cooperation with the Banner University Medical Center in Tucson, Arizona.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top